Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Hypofractionated Radiotherapy for Thymic Epithelial Tumors

NCT06692062 is registered in ClinicalTrials.gov with Rongrong Zhou as lead sponsor.

NCT NCT06692062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06692062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Hypofractionated Radiotherapy for Thymic Epithelial Tumors
Lead sponsor
Rongrong Zhou
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2024
Completion date
November 1, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thymic cancer, thymic epithelial tumor, thymoma, thymoma and thymic carcinoma